Tema ETFs’s Ionis Pharmaceuticals IONS Stock Holding History

Tema ETFs’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$121K	Sell	2,704 -2,821	-51%	-$160K	﹤0.01%	563
2026 Q2	$438K	Sell	5,525 -148	-3%	-$11.1K	0.01%	432
2026 Q1	$426K	Sell	5,673 -2,884	-34%	-$228K	0.03%	396
2025 Q4	$677K	Sell	8,557 -3,749	-30%	-$282K	0.05%	302
2025 Q3	$805K	Sell	12,306 -15,855	-56%	-$774K	0.07%	293
2025 Q2	$1.11M	Buy	28,161 +3,020	+12%	+$98.8K	0.3%	104
2025 Q1	$759K	Sell	25,141 -31,703	-56%	-$1.04M	0.23%	98
2024 Q4	$1.99M	Buy	+56,844	New	+$2.12M	0.83%	37

Other funds holding IONS

Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Nicollet Investment Management Minneapolis, Minnesota $336M AUM 22.24% 1-Year Est. Return

Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Cypress Capital Franklin, Tennessee $377M AUM 11.3% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Frank Rimerman Advisors Palo Alto, California $1.81B AUM 32.96% 1-Year Est. Return

Tema ETFs's IONS Position: Q3 2026 in Review

Tema ETFs reduced its Ionis Pharmaceuticals (IONS) stake by 51% in Q3 2026, selling an estimated $160K and leaving 2,704 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #563.

Tema ETFs first reported a position in IONS in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.99M in Q4 2024. 52 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

Tema ETFs held 2,704 shares of Ionis Pharmaceuticals worth $121K as of Q3 2026.
Tema ETFs sold 2,821 Ionis Pharmaceuticals shares in Q3 2026, an estimated $160K.
Ionis Pharmaceuticals made up ﹤0.01% of Tema ETFs's portfolio in Q3 2026, its #563 holding.
Tema ETFs first reported a position in Ionis Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
Tema ETFs's Ionis Pharmaceuticals position peaked at $1.99M in Q4 2024.
52 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on Tema ETFs's 13F filing for Q3 2026, filed 16 Oct 2026.